top of page

BIOTECHNOLOGY EVIDENCE BASE!

  • May 31, 2022
  • 2 min read

Updated: Feb 1, 2024

EVIDENCE BASE PROOF OF BIOTECHNOLOGY FOUNDATION NIH RESEARCH PAPER

"Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of

Molecular Neurobiological Mechanisms"

Read Full Article:


WE ARE THE FUTURE OF HIGH ACUITY ADDICTION MEDICAL CARE & EVIDENCE BASED NAD+ INFUSION CARE! 1. NAD+ NEUROPEPTIDE TREATMENTS 2. RESTORITROL: IV NTR3 NEURO 3. RESTORITRAL: IV TB2R4 TOTAL 4. ADDICTED BRAINS DO RECOVER NEUROPHYSIOLOGICALLY *Clients Will Have Recovery Results in Days vs Years! *Clients Will Have Better CBT-DBT Cognitive Restructuring Outcomes! *Clients Will Have Their Medications Working Better! *Clients Will Have Better Overall Long-Term Cognitive Functioning!


WE ARE THE FUTURE OF HIGH ACUITY ADDICTION MEDICAL CARE & EVIDENCE BASED NAD+ INFUSION CARE! *Advanced Medical Infusion Biomedical-Biotechnology! *Evidence Based, Researched, Validated & Reproduced! *Treating Addiction at The Molecular & Physiologic Core! *To be Used Only in Conjunction of Concurrent SAMHSA-ASAM

Validated & JC Accredited Treatment Programing!


RESTORITROL: IV NTR3 NEURO INFUSION THERAPY "HEALS" 1. Repairs Dopamine RDS IE: Reward Deficiency Syndrome 2. Restores All Down Stream "Feel Good Molecules" IE: Serotonin 3. Regenerates Dopamine Neurotransmitter Receptors IE: D2DR 4. Rebalances Dopamine Cascade Reward Circuitry IE: Limbic System 5. Reoptimizes All Neural Cell Mitochondria IE: Quadrillions 6. Recorrects and In Most Cases Eliminates PAWS IE: Cravings 7. Reactivates Cellular Anti-Aging Processes IE: RNA-DNA Production 8. Retitrates Medication Efficacy & Potency IE: Meds Work Better 9. Reimbursed by Insurance IE: CMS AETNA, CIGNA, UHC, BCBS, BEACON, TRICARE, HUMANA, ETC...


*Here is the lead paper for Our Technology and Proof that It Works! 261 Peer Reviewed Papers & 20 years of Evidence Based Clinical Research Science behind this biotechnology backed by International Peer Review Publications.

Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms (1) Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms | Marlene Oscar-Berman - Academia.edu



ree



ree


 
 
 

Comments


Neuroscience Institute on Addiction  Recovery

  • Facebook
  • YouTube

© 2023-2030 Website & Brand is a Registered USPTO for All Copyrights,

Trademarks, Patents & International Publications 

All Rights Reserved

USPTO-FDA-NIH-NCBI-NLM-PUBMED-CMS-DHS-DOD-DARPA

Vetted Registered Clearance Identification Numbers:

USGOV-SAM-SBIR: JAC6JJKYAF77JJ / DUN#: 013428223 / CAGE: 8TT10 / NAICS: 541611 

NATIONAL PROVIDER NUMBERS (NPIs): 1467193623/1083355119

Due Diligence Disclosure Reviews, Alignments & Match Verifications:

UNITED STATES GOVERNMENT: FDA. SBIR, NIH, USPTO, FEDERAL NIH-NIDA RFA, DoD CAGE-NAICS, GRANTS.GOV,

DUN & BRADSTREET, STATE LLC-501c3 REGISTRATION, TOP TEIR INSURANCE CARRIER CONTRACT CREDENTIALED,

ETHEREUM, FACEBOOK-META-MULTIVERSE-NFT, PAYPAL & VENMO CORPORATE, BANK OF AMERICA CORPORATE ZELLE,

AMAZON VETTED PARTNERSHIP BUSINESS

bottom of page